|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Tracking Information | |
|---|---|
| First Received Date ICMJE | May 8, 2002 |
| Last Updated Date | June 27, 2008 |
| Start Date ICMJE | July 2002 |
| Primary Completion Date | |
| Current Primary Outcome Measures ICMJE |
Safety Assessments |
| Original Primary Outcome Measures ICMJE | Same as current |
| Change History | Complete list of historical versions of study NCT00036361 on ClinicalTrials.gov Archive Site |
| Current Secondary Outcome Measures ICMJE |
Safety Assessments |
| Original Secondary Outcome Measures ICMJE | Same as current |
| Descriptive Information | |
| Brief Title ICMJE | Broad Effectiveness: Study With Aripiprazole |
| Official Title ICMJE | Broad Effectiveness: Study With Aripiprazole |
| Brief Summary | The purpose of this study is to learn if aripiprazole is effective in the treatment of a large number of persons diagnosed with schizophrenia or schizoaffective disorders |
| Detailed Description | |
| Study Phase | Phase III |
| Study Type ICMJE | Interventional |
| Study Design ICMJE | Treatment, Non-Randomized, Open Label, Active Control, Parallel Assignment, Safety Study |
| Condition ICMJE |
|
| Intervention ICMJE | Drug: Aripiprazole |
| Study Arms / Comparison Groups | |
| Publications * | |
|
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|
| Recruitment Information | |
| Recruitment Status ICMJE | Completed |
| Enrollment ICMJE | 444 |
| Completion Date | |
| Primary Completion Date | |
| Eligibility Criteria ICMJE | - Patients with Schizophrenia or Schizoaffective Disorder |
| Gender | Both |
| Ages | 18 Years to 75 Years |
| Accepts Healthy Volunteers | No |
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects |
| Location Countries ICMJE | United States |
| Administrative Information | |
| NCT ID ICMJE | NCT00036361 |
| Responsible Party | |
| Study ID Numbers ICMJE | CN138-087 |
| Study Sponsor ICMJE | Bristol-Myers Squibb |
| Collaborators ICMJE | Otsuka America Pharmaceutical |
| Investigators ICMJE | |
| Information Provided By | Bristol-Myers Squibb |
| Verification Date | September 2007 |
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|